Tsujimoto, Kimberley C.
Cost, Katherine Tombeau
LaForge-MacKenzie, Kaitlyn
Anagnostou, Evdokia
Birken, Catherine S.
Charach, Alice
Monga, Suneeta
Kelly, Elizabeth
Nicolson, Rob
Georgiadis, Stelios
Lee, Nicole
Osokin, Konstantin
Arnold, Paul
Schachar, Russell
Burton, Christie
Crosbie, Jennifer
Korczak, Daphne J. http://orcid.org/0000-0002-0061-7495
Funding for this research was provided by:
Canadian Institutes for Health Research (173092)
Ontario Ministry of Health and Long-Term Care (700)
Centre of Brain and Mental Health, SickKids
Leong Centre for Healthy Children, SickKids
Minister's Lamp Innovation Fund in Prevention and Early Detection of Severe Mental Illness, University of Toronto
Ontario Brain Institute
Canadian Institutes of Health Research (PJT-159462)
Article History
Accepted: 26 October 2022
First Online: 24 November 2022
Declarations
:
: EA has received consultation fees from Roche and Quadrant, grant funding from Roche and in-kind support from Amo Pharma. She holds a patent for the device, “Tully” (formally “Anxiety Meter”). She has received royalties from APPI and Springer, and editorial honoraria from Wiley.The authors have no competing commercial interests related to this study.